Baquiano, Cristina F.

HRN: 28-62-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/26/2026
03/04/2026
IV
500mg
Q8
Intraabdominal Infection; Acalculous Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: